account_id none on file
legal_name MoonLake Immunotherapeutics
ticker MLTX
cik 1821586
domain moonlaketx.com
linkedin_company_url https://www.linkedin.com/company/moonlake-immunotherapeutics-ag/
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 3 executives 1 family 0
why_nownone on file
callsnone on file
filings
On July 1, 2026, the Company entered into a new lease agreement for a corporate office space in the United States with a lease term of approximately 11 years.
filing / Aug 10, 2026 / receipt
These future lease commitments relate to the office leases for our headquarters in Zug, Switzerland, Cambridge, United Kingdom, and Porto, Portugal, and reflect minimum payments due.
filing / May 11, 2026 / receipt
In August 2021, the Company entered into an open-ended office lease agreement, effective November 1, 2021, to lease approximately 2,300 square feet of space on the last two floors of the building located at Dorfstrasse 29, 6300 Zug, Switzerland.
filing / May 11, 2026 / receipt
executives
| Andrew Phillips | Chief Financial Officer | - | receipt |
familynone on file
upcoming
changes
mcp_package_hint
slug moonlake-immunotherapeutics
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$